Appointment Consolidates Leadership of Vascular Intervention and
Lead Management Businesses
Spectranetics Corporation (Nasdaq:SPNC) today announced the appointment
of Jason Hein to the position of Senior Vice President, Sales, Marketing
and Product Development for both the Vascular Intervention and Lead
Management businesses. Also, Renee Boehme, Director, Lead Management
Sales has been promoted to Vice President, U.S. Sales -- Lead Management.
Spectranetics Chairman, President and Chief Executive Officer Emile
Geisenheimer commented, “The promotion of Jason into his new role
consolidates the leadership of our Vascular Intervention and Lead
Management businesses, allowing us to streamline decision making and
enhance operating efficiencies as we continue our drive towards
profitability. I continue to be excited about the revenue growth
prospects in both the Vascular Intervention and Lead Management
businesses, which growth is driven by the strength of their respective
highly capable field sales organizations.
“Since joining Spectranetics in July 2006, Jason has implemented several
significant initiatives in the Lead Management business, including the
creation of a separate sales organization, implementation and successful
conclusion of the LExICon retrospective study supporting positive
clinical outcomes utilizing laser-assisted lead extraction, and an
impressive showcase of Spectranetics lead management products at the
recently concluded Heart Rhythm Society meeting, where the guidelines
for lead extraction were expanded. He has built an exceptional
management team and has proven himself to be a strong leader, resulting
in the rapid rate of growth in our Lead Management business. I look
forward to working with Jason in his expanded role,” said Geisenheimer.
Mr. Geisenheimer concluded, “This reorganization eliminates the position
of Vice President, General Manager, Vascular Intervention.”
About Spectranetics
Spectranetics manufactures and markets the only Excimer Laser System
approved in the United States, Canada, Europe and Japan for use in
minimally invasive interventional procedures within the cardiovascular
system. More than 800 Spectranetics laser systems are used in hospitals
worldwide.
The Company’s Vascular Intervention (VI) products include a range of
peripheral and cardiac laser catheters for ablation of occluded arteries
above and below the knee and within coronary arteries.
